With an experienced team comprised of around 200 highly skilled professionals, the company is able to span the entire value chain of biosimilar drug development, from market analysis and target definition by protein analytics, to the development of production processes, to clinical trials and the regulatory approval process. * Proactively originate early stage partnering opportunities for new portfolio additions like co-development agreements, based on a deep understanding of global market dynamics * Take full ownership of alliance management in late‑stage, launch, and post‑launch phases, ensuring strong profitability from existing partnerships and resolving execution challenges in advanced project stages * Senior‑level experience in licensing, business development, and alliance management within generic or biotech companies, ideally with biosimilars focus
mehr